Journal Reviews

Intravitreal bevacizumab vs. triamcinolone in patients with DMO at the time of cataract surgery

1 October 2016 | | Retina / Uvea / Vitreous | bevacizumab, cataract surgery, diabetic macular oedema, randomized clinical trial, triamcinolone

This prospective, single masked randomised control trial (RCT) compared visual and anatomical outcomes when either intravitreal bevacizumab (BVB) or triamcinolone (TA) was administered at the time of cataract surgery and at subsequent review, if required, in patients with diabetic macula...